Empatica
Empatica is a leader in digital biomarker development, holding the first FDA-cleared digital biomarker in neurology. The company offers the Empatica Health Monitoring Platform, an end-to-end remote monitoring solution for clinical trials and academic research. This platform utilizes award-winning, FDA-cleared medical technology, including the EmbracePlus wearable and the Care software suite, to collect and monitor raw data and digital biomarkers. Empatica's technology is used by over half of the top 20 pharmaceutical companies to monitor treatment impact and develop digital endpoints. Their products are available in over 160 countries and have been deployed on over 100,000 devices, supporting more than 12,000 research papers. The company focuses on providing a scalable, modular, and reliable platform for remote health monitoring and data collection.
Empatica
Empatica is a leader in digital biomarker development, holding the first FDA-cleared digital biomarker in neurology. The company offers the Empatica Health Monitoring Platform, an end-to-end remote monitoring solution for clinical trials and academic research. This platform utilizes award-winning, FDA-cleared medical technology, including the EmbracePlus wearable and the Care software suite, to collect and monitor raw data and digital biomarkers. Empatica's technology is used by over half of the top 20 pharmaceutical companies to monitor treatment impact and develop digital endpoints. Their products are available in over 160 countries and have been deployed on over 100,000 devices, supporting more than 12,000 research papers. The company focuses on providing a scalable, modular, and reliable platform for remote health monitoring and data collection.
TL;DR
Primary offering: Empatica Health Monitoring Platform — FDA-cleared wearable devices (Embrace family) plus cloud Research Portal
Markets / use cases: Clinical trials, academic research, remote patient monitoring
Scale: Deployed on 100,000+ devices and available in 160+ countries
Funding signal: Series B (latest disclosed); investors include RA Capital Management and Sanofi Ventures
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Remote patient monitoring, digital biomarker development, clinical trial data collection
Founded
2011
Industry
Biotechnology Research
Tech Stack
Funding Track Record
Latest disclosed round
Investor Signal
“Backed by venture investors including RA Capital Management, Sanofi Ventures, Innogest Capital, Invitalia Ventures, Endeavor Catalyst, Bossa Invest, Black Opal Ventures”